The global kaposi sarcoma market is currently valued at more than USD 122 million and is expected to reach around USD 135 million by 2021, says Technavio.
Technavio has announced its latest market research report on the global Kaposi sarcoma market, under its oncology portfolio. This market analysis discusses the major drivers and key emerging trends and offers an analysis of key vendors like Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, and Merck.
According to Barath Palada, a lead analyst for oncology research at Technavio, “Organ transplant process is becoming increasingly popular and is being widely adopted on a global scale. The rising improvement rate in the post-transplant outcomes and increasing success rate has led to high adoption of organ transplants.”
The major transplant activities are done for the organs such as kidney, pancreas, livers, lungs, and heart. During 2015, the US witnessed more than 5% annual growth in organ transplant, taking the total number to approximately 31,000.
Click here to request a free sample of this report
Increasing consolidation in the cancer treatment market
The global market is currently experiencing a rise in consolidation of vendors in the cancer treatment market. This trend is expected to further increase during the forecasted period. For instance, in March 2015, Novartis completed its transaction with GlaxoSmithKline, including the acquisition of its oncology portfolio and some other businesses. The Kaposi sarcoma market is highly concentrated, and various initiatives in cancer treatment between vendors, and between hospitals and clinics are expected to further consolidate the market in the coming years.
Application of Kaposi sarcoma-specific treatment (local treatment)
The application of Kaposi sarcoma-specific treatments such as topical treatments, injections, or radiotherapy is an upcoming trend in the global market for Kaposi sarcoma. For instance, topical retinoid treatment involves applying the medicine directly on the lesion. Panretin, a retinoid drug related to vitamin A, is one such drug available for the treatment of Kaposi sarcoma skin lesion. Radiation therapy is another suitable option available for the treatment of Kaposi sarcoma. These radiations are used for the reduction of symptoms of the disease such as swelling or pain.
This research report includes an in-depth analysis and market shares and sizes of the sub-segments and geography. An analysis of the key companies, including their market shares, business overview, key financials, etc. is provided in this study. This market study also provides a detailed analysis of key drivers, challenges, and opportunities influencing this market.
A more detailed analysis is available in the Technavio report titled, ‘Global Kaposi Sarcoma Market 2017-2021’. Technavio also customizes reports by other regions and specific segments upon request.
Other related reports:
- Global Multiple Myeloma Drugs Market 2017-2021
- Global Cancer Monoclonal Antibodies Market 2017-2021
- Global Lung Cancer Therapeutics Market 2016-2020
To read more press releases – click here
